One small study found no increased risk of major birth defects or miscarriage among women who took GLP-1 RAs during their first trimester
Who Should and Shouldn't Combine These Compounds: Clinical Eligibility The combination may be most appropriate for patients with PCOS, metabolic syndrome, or insulin resistance who are using tirzepatide for weight management or glycemic control
At Blue Horizon, we believe that navigating these choices requires a clear, evidence-based understanding of how your body works as a whole system
If the combination proves effective, it could be a game-changer for the millions of people who have plateaued on GLP-1 medications or who have regained weight after stopping them
The most important challenge is understanding what weve actually found
That said, daily consistency is what drives colonization and sustained metabolite production